Amblyotech

Amblyotech

Developer of novel electronic media therapies designed for the treatment of amblyopia and other ocular diseases.

HQ location
Atlanta, United States
Website
amblyotech.com
Launch date
Enterprise value
$2—2m
Recent deals
https://twitter.com/novartishttps://www.facebook.com/610959839003874
    • Edit
loading funding rounds…
Novartis
Novartis
Jumpstart Foundry
Jumpstart Foundry(exited)

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Amblyotech

Edit
Intellia Therapeutics
Intellia Therapeutics
exited
XOMA
XOMA
exited
Aduro BioTech
Aduro BioTech
exited
Ayala Pharmaceuticals
Ayala Pharmaceuticals
exited
Poseida Therapeutics
Poseida Therapeutics
ACQUISITION by Roche Nov 2024
Immunitas Therapeutics
Immunitas Therapeutics
Dunad Therapeutics
Dunad Therapeutics
Medtech Africa
Medtech Africa